Since many of these comorbidities are also reported to be closely associated with ACE1 I/D polymorphisms, we proposed previously that these individuals may have a mild ACE1/ACE2 imbalance before viral infection, which increases their risk for developing severe cases of COVID-19 [18]. This evidence concerns the gene ACE and COVID-19.